United Capital Financial Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Buy |
|
|||||
|
2025
Q1 | $2.24M | Sell |
|
|||||
|
2024
Q4 | $2.9M | Sell |
|
|||||
|
2024
Q3 | $3.84M | Buy |
|
|||||
|
2024
Q2 | $3.84M | Sell |
|
|||||
|
2024
Q1 | $3.35M | Sell |
|
|||||
|
2023
Q4 | $3.52M | Sell |
|
|||||
|
2023
Q3 | $4.74M | Buy |
|
|||||
|
2023
Q2 | $4.62M | Buy |
|
|||||
|
2023
Q1 | $3.58M | Buy |
|
|||||
|
2022
Q4 | $2.34M | Sell |
|
|||||
|
2022
Q3 | $2.18M | Sell |
|
|||||
|
2022
Q2 | $2.84M | Sell |
|
|||||
|
2022
Q1 | $3.31M | Sell |
|
|||||
|
2021
Q4 | $2.96M | Buy |
|
|||||
|
2021
Q3 | $2.63M | Buy |
|
|||||
|
2021
Q2 | $2.19M | Sell |
|
|||||
|
2021
Q1 | $1.83M | Sell |
|
|||||
|
2020
Q4 | $1.95M | Buy |
|
|||||
|
2020
Q3 | $407K | Sell |
|
|||||
|
2020
Q2 | $571K | Sell |
|
|||||
|
2020
Q1 | $507K | Sell |
|
|||||
|
2019
Q4 | $1.66M | Buy |
|
|||||
|
2019
Q3 | $606K | Sell |
|
|||||
|
2019
Q2 | $1.34M | Buy |
|
|||||
|
2019
Q1 | $1.15M | Sell |
|
|||||
|
2018
Q4 | $1.16M | Buy |
|
|||||
|
2018
Q3 | $1.06M | Buy |
|
|||||
|
2018
Q2 | $814K | Buy |
|
|||||
|
2018
Q1 | $627K | Buy |
|
|||||
|
2017
Q4 | $449K | Buy |
|
|||||
|
2017
Q3 | $365K | Buy |
|
|||||
|
2017
Q2 | $338K | Buy |
|
|||||
|
2017
Q1 | $300K | Buy |
|
|||||
|
2016
Q4 | $234K | Buy |
|
|||||
|
2016
Q3 | $269K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $308K | Sell |
|
|||||
|
2015
Q4 | $447K | Sell |
|
|||||
|
2015
Q3 | $686K | Sell |
|
|||||
|
2015
Q2 | $377K | Sell |
|
|||||
|
2015
Q1 | $843K | Buy |
|
|||||
|
2014
Q4 | $537K | Sell |
|
|||||
|
2014
Q3 | $589K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $389K | Buy |
|